- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4436 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
Patent holdings for IPC class A61K 31/4436
Total number of patents in this class: 1001
10-year publication summary
|
70
|
86
|
75
|
59
|
87
|
62
|
49
|
67
|
71
|
39
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10175 |
21 |
| Janssen Pharmaceutica N.V. | 3160 |
14 |
| Takeda Pharmaceutical Company Limited | 2699 |
14 |
| Bristol-myers Squibb Company | 4764 |
13 |
| Bausch Health Ireland Limited | 802 |
13 |
| Epizyme, Inc. | 360 |
12 |
| Allergan, Inc. | 2155 |
11 |
| Astellas Pharma Inc. | 1040 |
10 |
| Cardioxyl Pharmaceuticals, Inc. | 38 |
10 |
| Trevena, Inc. | 61 |
10 |
| Union Therapeutics A/S | 58 |
10 |
| The Regents of the University of California | 20842 |
9 |
| io Therapeutics, Inc. | 125 |
9 |
| Chiesi Farmaceutici S.p.A. | 952 |
8 |
| Gilead Sciences, Inc. | 2242 |
8 |
| HMI Medical Innovations, LLC | 14 |
8 |
| Sol-gel Technologies Ltd. | 117 |
8 |
| Merck Sharp & Dohme LLC | 3738 |
8 |
| F. Hoffmann-La Roche AG | 7800 |
7 |
| Shire Human Genetic Therapies, Inc. | 190 |
7 |
| Other owners | 791 |